Answers are grounded in this paper and cite their sources.
Utilization of homoeopathic treatment in patients with diabetes and hypertension can potentially affect the disclosure, reconciliation and clinical communication of medications; however, there is limited predictive evidence of this. This study designed and internally validated an explainable artificial intelligence (XAI) based decision support system with secondary multi-centre cross-sectional data of 400 Bangladeshi adults. Demographic knowledge and attitude variables, clinical knowledge and attitude variables and CAM related knowledge and attitude variables were used in the modelling of the Homoeopathic utilization. The models were penalized logistic regression, Random Forest and XGBoost models which were assessed with repeated nested cross validated analysis, uncertainty estimation using bootstrapping, probability calibration, explainability using SHAP values, sensitivity analysis and decision curve analysis. The number of participants who reported on Homoeopathy was 59 (14.75%). The calibrated extended random forest had the highest overall performance with an ROC-AUC of 0.7893, an average precision score of 0.3530 and a Brier score of 0.1082. Perceived CAM effectiveness, perceived CAM safety and age were the most influential and consistently ranked predictors. Observed utilization increased from 3.7% in the low-risk group to 22.1% and 33.3% in the intermediate- and high-risk groups, respectively. The framework showed a positive net benefit within clinically relevant thresholds and may facilitate targeted inquiry/disclosure, medication reconciliation, and communication of safety when using CAM. External validation is needed prior to clinical routine use.
No takes yet. Share an insight, caveat, or question.
Lathiya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: